Article Contents ::
- 1 The Brand Name EXELON Has Generic Salt :: Rivastigmine
- 2 EXELON Is From Company Novartis Priced :: Rs. N.I./N.I.
- 3 EXELON have Rivastigmine is comes under Sub class Drugs for Neurodegenerative Disorders of Main Class Nervous System
- 4 Main Medicine Class:: Nervous System Sub Medicine Class :: Drugs for Neurodegenerative Disorders
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
The Brand Name EXELON Has Generic Salt :: Rivastigmine
EXELON Is From Company Novartis Priced :: Rs. N.I./N.I.
EXELON have Rivastigmine is comes under Sub class Drugs for Neurodegenerative Disorders of Main Class Nervous System
Main Medicine Class:: Nervous System Sub Medicine Class :: Drugs for Neurodegenerative Disorders
|Salt Name : OR Generic Name||Form||Price : MRP /Probable||Packing|
Indications for Drugs ::
Severe dementia in Alzheimer’s disease.
Drug Dose ::
Oral Mild to moderately severe dementia in Alzheimer’s disease Adult: Initially, 1.5 mg bid, increased according to response by 1.5 mg bid at intervals of at least 2 wk. If treatment is interrupted for >a few days, restart at 1.5 mg bid and increase dose accordingly, if required. Max: 6 mg bid. Transdermal Indicated for mild, moderate, and severe dementia of the Alzheimer’s type Initial: Apply 4.6 mg q24hr Dose titration: May increase dose to 9.5 mg q24hr after a minimum 4 weeks if well tolerated; after an additional 4 weeks, may further increase to 13.3 mg patch if needed Mild-to-moderate Alzheimer disease: Effective dosage range is 9.5-13.3 mg/24 hr Moderate-to-severe Alzheimer disease: Effective dose is 13.3 mg/24 hr Replace with new patch q24hr
Hypersensitivity to other carbamate derivatives. Severe hepatic impairment.
Drug Precautions ::
Patients with sick sinus syndrome or conduction defects, resp diseases. Cholinergic stimulation may increase gastric acid secretion. May exacerbate urinary obstruction and seizures. Pregnancy. Renal impairment, mild to moderate hepatic impairment. Monitor body wt. Asthma or obstructive pulmonary disease. May worsen extrapyramidal symptoms. Lactation.
Drug Side Effects ::
Accidental trauma, fatigue, asthenia, dizziness, headache, somnolence, agitation, insomnia, confusion, depression, nausea, vomiting, diarrhoea, abdominal pain, loss of appetite, dyspepsia, upper respiratory tract infection, urinary tract infection. Rarely, angina pectoris, gastric and duodenal ulcers, GI haemorrhage; bradycardia, seizures, rashes and syncope. Potentially Fatal: Serious GI reactions such as anorexia, vomiting and weight loss.
Pregnancy category ::
Drug Mode of Action ::
Rivastigmine reversibly inhibits hydrolysis of acetylcholine by cholinesterases thus increasing acetylcholine present in the CNS. It is selective for the CNS and is used for the symptomatic treatment of dementia in Alzheimer’s disease and idiopathic Parkinson’s disease.
Drug Interactions ::
Not to be used with other cholinomimetic drugs that might interfere with the activity of anticholinergic medications. May exaggerate the effects of succinylcholine-type muscle relaxants during anaesthesia. Tobacco smoking may increase its clearance.